
Rashmi K. Murthy, MD, MBE, MD Anderson Cancer Center
Advertisement
Articles by Rashmi K. Murthy, MD, MBE, MD Anderson Cancer Center














Rashmi K. Murthy, MD, MBE, discusses results of the HER2CLIMB trial in previously treated HER2-positive breast cancer.
Advertisement
Latest Updated Articles
Dr. Murthy on HER2CLIMB Trial Results in HER2+ Breast CancerPublished: December 12th 2019 | Updated:
TRAIN-2: Anthracyclines in HER2+ Breast CancerPublished: June 30th 2020 | Updated:
Biomarker Data After Neoadjuvant Therapy for HER2+ Breast CancerPublished: June 30th 2020 | Updated:
Guidelines and Approaches to HER2 Testing for Breast CancerPublished: June 30th 2020 | Updated:
HER2CLIMB: Brain Metastases DataPublished: June 30th 2020 | Updated:
Treatment Choice for Patient Relapsing With Brain MetastasesPublished: June 30th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Unpacking the FDA Approvals That Reshaped Cancer Care in 2025
2
Nogapendekin Alfa Inbakicept Plus NK Cell Therapy Yields Strong OS Signal in Recurrent Glioblastoma
3
Immune-Targeting Vaccine Shows Promise Intercepting Cancer in Patients With Lynch Syndrome
4
FDA Grants Orphan Drug Designation to Gotistobart in Squamous NSCLC
5

